al

ACS cancels spring national meeting in Philadelphia

Concerns over the spread of the novel coronavirus leads to decision




al

How international students can share their culture in the lab

Creating more opportunities for dialogue is just the first step




al

Firmenich to buy French pine chemical firm

DRT brings sustainable fragrance ingredients and industrial additives




al

EPA overhauls pesticide biological evaluations

Agency's approach for assessing risks to endangered species relies on real-world data




al

Bryan Brooks named editor in chief of <i>Environmental Science and Technology Letters</i>




al

AI specialist Atomwise signs with Bridge Biotherapeutics




al

ACS cancels spring national meeting in Philadelphia

#ACSPhilly is one of many scientific conferences postponed or canceled because of concerns over COVID-19




al

OMV to raise stake in Borealis




al

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




al

Researchers grow thin 2-D insulator on large scale

Single-crystal boron nitride could enable the use of 2-D materials for transistors in computer chips




al

Mechanical chirality gives new shape to catalysis

Mechanically chiral rotaxane creates a catalytic pocket a little like an enzyme




al

How one country is grappling with mercury emissions from artisanal gold shops

Peru seeks to keep rudimentary gold refining from exposing communities to neurotoxic metal




al

Petrochemical makers look ahead to an uncertain decade

The past 10 years have been great for US ethylene producers, but they doubt a repeat performance




al

As telecom demands grow, optical fibers will need to level up

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data




al

How small chemical company leaders are dealing with the coronavirus

Specialty chemical CEOs are rolling with the punches to keep their firms going




al

Air quality improvements boosted California's agriculture industry

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost




al

A radial setup helps automated synthesis branch out

Reactors arranged around a central switching station gives chemists more options for making molecules remotely




al

COVID-19 coronavirus weighs on economy, chemicals

Chemical makers and oil producers are pulling back on production, reconsidering investments




al

Chemistry departments deal with coronavirus closures

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists




al

ACS launches virtual platform for sharing research from Philadelphia national meeting

Posters and presentations can be uploaded to SciMeetings starting on March 19




al

BASF, Clariant postpone annual meetings




al

Huntsman to acquire CVC from Emerald




al

Harnessing cells to build functional materials

Polyaniline coating changes the firing frequency of targeted neurons




al

Evonik rolls out nonanimal collagen




al

New Zealand invests in wind-powered hydrogen plant




al

ACS Scholar alumnus: Bart Bartlett

Current ACS Scholar Rebecca Leuschen chats with this University of Michigan professor about motivation




al

EPA overhauls pesticide biological evaluations

Agency's approach for assessing risks to endangered species relies on real-world data




al

How companies are getting 1,4-dioxane out of home and personal care products

Chemical makers, cleaning product firms, and cosmetics makers are all scrambling to meet new limits on the impurity




al

Why Japan's chemical firms still make drugs

They persist in the pharma business, even as chemical companies in the West have mostly exited




al

2020 Priestley Medalist JoAnne Stubbe digs deep into the details of enzymes

The MIT biochemist's intense focus has helped her solve some of biochemistry's important puzzles




al

Priestley Medal address 2020: The road less traveled—for love of detection, discovery, and all things radical in nature




al

3-D printing firms rise to coronavirus challenge

Companies are making their machines and expertise available to hospitals in need of parts




al

Crystal structures of the novel coronavirus protease guide drug development

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19




al

Lemos confirmed as chair of the US Chemical Safety Board




al

Chemical firms say they want to keep going

Industry is deemed essential critical infrastructure by federal and state governments




al

Adding two functional groups to an aliphatic alcohol in one shot

The simple reaction could be an easy way to synthesize new molecules for drug discovery




al

Not all US science agencies are prepared for sexual harassment claims

Only NIH, NSF publicize their complaint procedures




al

Protein mapping finds 69 potential treatments for COVID-19

Many are FDA-approved drugs that could be repurposed




al

Eliminating catalyst defects boosts activity and extends lifetime

Nearly perfect, long-lasting crystalline catalyst turns CO<sub>2</sub> into valuable products




al

Tension but also harmony over COVID-19 in Europe's chemical industry

Italian workers threaten to strike, but German, UK companies and workers pull together




al

Vaping exposes users to more toxic metals than smoking cigarettes

E-cigarettes deliver lead, arsenic, nickel, and other metals at harmful levels




al

Emory-discovered antiviral is poised for COVID-19 clinical trials

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans




al

Sumitomo Chemical plans sustainable R&amp;D group




al

ACS launches virtual platform for sharing research from Philadelphia national meeting




al

Chemical companies tighten their belts




al

All hands to the sanitizer pump




al

3-D printing firms rise to coronavirus challenge

Companies are making their machines and expertise available to hospitals in need of parts




al

AlloVir and Baylor to make donor-derived T cell therapies that target coronaviruses




al

Design Therapeutics launches with $45 million for neurological diseases




al

Thermo Fisher to invest $475 million in biopharmaceutical services